amsacrine - CISMeF

Preferred Label : amsacrine;

MeSH definition : An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.;

MeSH synonym : amsa; cains acridine; cain acridine; cain's acridine; meta-amsa; meta amsa; m-amsa;

CISMeF synonym : acridine, cain's; amsacrine gödecke brand; gödecke brand of amsacrine; parke davis brand of amsacrine; parke davis brand of amsacrine lactate;

MeSH hyponym : NSC-141549; SN-11841; amsidine; NSC-249992; NSC-156303; amsidyl; SN 11841; SN11841; NSC 156303; NSC156303; NSC 249992; NSC249992; Amsacrina; AMSA P-D; AMSA P D; AMSA PD; NSC 141549; NSC141549;

MeSH CAS label : methanesulfonamide, N-(4-(9-acridinylamino)-3-methoxyphenyl)-;

MeSH Related Number : 51264-14-3;

Registry Number MeSH : 51264-14-3;

Wikipedia link : https://en.wikipedia.org/wiki/Amsacrine;

Codes EINECS : 257-094-3;

Is substance : O;

UNII : 00DPD30SOY;

Details

Origin ID

D000677;

UMLS CUI

C0002699;

ATC code(s)
- amsacrine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Amsacrine [ICHI extension code]
- M-AMSA [ICHI extension code]
CISMeF manual mappings
- Amsacrine poisoning (disorder) [SNOMED CT concept]
- amsacrine [Substance BNPC]
Currated CISMeF NLP mapping
- Amsacrine [ICD-11 Extension code]
- Amsacrine [NCIt concept]
- Amsacrine (substance) [SNOMED CT concept]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- intercalating agents [MeSH Descriptor]
Record concept(s)
- NSC-141549 [MeSH concept]
- NSC-156303 [MeSH concept]
- NSC-249992 [MeSH concept]
- SN-11841 [MeSH concept]
- amsacrine [MeSH concept]
- amsidine [MeSH concept]
- amsidyl [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-methylamsacrine [MeSH Supplementary Concept]
- 3,6-diamino-1'-dimethyl-9-anilinoacridine [MeSH Supplementary Concept]
- 3-azidoamsacrine [MeSH Supplementary Concept]
- 4'-(9-acridinylamino)methanesulfon-o-anisidide [MeSH Supplementary Concept]
- 4-(9-acridinylamino)-N-(lysylglycyl)aniline [MeSH Supplementary Concept]
- 4-(9-acridinylamino)aniline [MeSH Supplementary Concept]
- 9-anilinoacridine [MeSH Supplementary Concept]
- ACE protocol 2 [MeSH Supplementary Concept]
- AEP protocol [MeSH Supplementary Concept]
- AML8A protocol [MeSH Supplementary Concept]
- AMSA-OAP protocol [MeSH Supplementary Concept]
- ATA protocol [MeSH Supplementary Concept]
- BAVC protocol [MeSH Supplementary Concept]
- CI 921-polyaldehyde dextran [MeSH Supplementary Concept]
- MAMI protocol [MeSH Supplementary Concept]
- MAZE protocol [MeSH Supplementary Concept]
- MRC AML 10 protocol [MeSH Supplementary Concept]
- N(1')-methanesulfonyl-N(4')-(9-acridinyl)-3'-methoxy-2',5'-cyclohexanediene-1',4'-diimine [MeSH Supplementary Concept]
- SN 16713 [MeSH Supplementary Concept]
- VABA protocol [MeSH Supplementary Concept]
- amsacrine-DNA [MeSH Supplementary Concept]
- amsacrine-tetrachloroplatinum dianion complex [MeSH Supplementary Concept]
- asulacrine [MeSH Supplementary Concept]
- methyl-N-(4-(9-acridinylamino)-2-methoxyphenyl)carbamate [MeSH Supplementary Concept]
- tetrakis-acridinyl peptide 1 [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- antineoplastic agents [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Amsacrine [ICD-11 Extension code]
- Amsacrine [NCIt concept]
- Amsacrine (substance) [SNOMED CT concept]
- Product containing amsacrine (medicinal product) [SNOMED CT concept]
- amsacrine [ATC Code]
- amsacrine [Substance BNPC]
Validated automatic mappings to BTNT
- amsacrine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients